Testicular cancer before and after cisplatin: a 30-year view

被引：0
作者：
Ansell, Wendy [1 ]
Shamash, Jonathan [1 ]
机构：
[1] St Bartholomews Hosp, London EC1A 7BE, England
来源：
INTERNATIONAL JOURNAL OF UROLOGICAL NURSING | 2008年 / 2卷 / 03期
关键词：
Historical perspective; Multidisciplinary working; Survivorship; Testicular cancer; Testicular germ cell tumours; Treatment advances;
D O I：
10.1111/j.1749-771X.2008.00060.x
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Exciting changes have been made in the management of testicular germ cell cancers over the past 30 years. Today, more than 80% of men who present with metastatic disease are cured compared with about 15% in the early 1970s. This means that there are a large number of survivors and many of them have willingly provided information that can be used in shaping the management of other malignancies. The paper aims to summarize the current management of testicular germ cell cancers comparing the situation in the pre-platinum era with that today and to consider current and future developments in the management of this disease.
引用
收藏
页码：103 / 112
页数：10
相关论文
共 50 条
  • [1] The cardiac impact of cisplatin-based chemotherany in survivors of testicular cancer: a 30-year follow-up
    Bjerring, Anders W.
    Fossa, Sophie D.
    Haugnes, Hege S.
    Nome, Ragnhild
    Stokke, Thomas M.
    Haugaa, Kristina H.
    Kiserud, Cecilie E.
    Edvardsen, Thor
    Sarvari, Sebastian, I
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (04) : 443 - 450
  • [2] Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data
    Zhou, Xianghong
    Zhang, Zilong
    Ruan, Cheng
    Wu, Yuwei
    Zeng, Bin
    Su, Xinyang
    Yuan, Qiming
    Li, Yifan
    Wei, Qiang
    Qiu, Shi
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (08) : 4633 - 4647
  • [3] Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
    Hellesnes, Ragnhild
    Kvammen, Oivind
    Myklebust, Tor A.
    Bremnes, Roy M.
    Karlsdottir, Asa
    Negaard, Helene F. S.
    Tandstad, Torgrim
    Wilsgaard, Tom
    Fossa, Sophie D.
    Haugnes, Hege S.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 21 - 32
  • [4] Cisplatin: CV changes in testicular cancer?
    Reactions Weekly, 2006, 1087 (1) : 3 - 3
  • [5] Cisplatin-based chemotherapy of testicular cancer - Two decades after a major breakthrough
    Gerl, A
    ONKOLOGIE, 2000, 23 (02): : 106 - 111
  • [6] Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer
    Altena, R.
    Hummel, Y. M.
    Nuver, J.
    Smit, A. J.
    Lefrandt, J. D.
    de Boer, R. A.
    Voors, A. A.
    van den Berg, M. P.
    de Vries, E. G. E.
    Boezen, H. M.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2286 - 2293
  • [7] Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
    Garcia, Sara L.
    Lauritsen, Jakob
    Christiansen, Bernadette K.
    Hansen, Ida F.
    Bandak, Mikkel
    Dalgaard, Marlene D.
    Daugaard, Gedske
    Gupta, Ramneek
    CANCERS, 2023, 15 (15)
  • [8] Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy
    Renée H. Martin
    Scott Ernst
    Alfred Rademaker
    Leona Barclay
    Evelyn Ko
    Nancy Summers
    Human Genetics, 1997, 99 : 214 - 218
  • [9] Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer
    Stouten-Kemperman, Myrle M.
    de Ruiter, Michiel B.
    Boogerd, Willem
    Kerst, J. Martijn
    Kirschbaum, Clemens
    Reneman, Liesbeth
    Schagen, Sanne B.
    BRAIN CONNECTIVITY, 2018, 8 (07) : 398 - 406
  • [10] Prevalence, changes in and correlates of fatigue in the first year after diagnosis of testicular cancer
    Fleer, J
    Sleijfer, DT
    Hoekstra, HJ
    Tuinman, MA
    Hoekstra-Weebers, JEHM
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4647 - 4653
12345